Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 14, 2025 16:32 ET | Source: Comstock Inc.

Comstock Announces Reverse Stock Split

VIRGINIA CITY, Nev., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Comstock Inc. ("Comstock") (NYSE American: LODE), a leading innovator of renewable energy-enabling technologies that contribute to energy...
February 14, 2025 10:26 ET | Source: Research and Markets

L-Aspartic Acid Zinc Salt (CAS 36393-20-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

Dublin, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The "L-Aspartic Acid Zinc Salt (CAS 36393-20-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been...
February 14, 2025 08:51 ET | Source: Grabar Law Office

Grabar Law Office is Investigating Claims On Behalf of Long-Term Shareholders of Extreme Networks, Inc. (NASDAQ: EXTR); Newmont Corporation (NYSE: NEM); Domino’s Pizza Corp. (NASDAQ: DPZ); and Olaplex Holdings, Inc. (NASDAQ: OLPX)

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Extreme Networks, Inc. (NASDAQ: EXTR): Grabar Law Office is investigating claims on behalf of Extreme Networks, Inc. (NASDAQ: EXTR)...
February 14, 2025 07:51 ET | Source: Research and Markets

USA Zinc Industry Report 2025: 2019-2024 Review and Forecast to 2029

Dublin, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The "Zinc Market in USA: 2019-2024 Review and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.This report is an essential...
February 14, 2025 07:08 ET | Source: Research and Markets

Chromium Zinc Oxide (CAS 50922-29-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Capacity, Production, Consumption, Manufacturing, End-users, Trade

Dublin, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The "Chromium Zinc Oxide (CAS 50922-29-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to...
February 13, 2025 19:00 ET | Source: Robbins Geller Rudman & Dowd LLP

NEM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Newmont Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Newmont Corporation (NYSE: NEM) securities between February 22, 2024 and...
February 13, 2025 17:54 ET | Source: DiCello Levitt LLP

INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Newmont Corporation (NYSE: NEM); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel

SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired Newmont Corporation (NYSE: NEM)...
February 13, 2025 16:53 ET | Source: Island Passage Development Canada Limited

Island Passage Exploration Summarizes 2024 and Launches 2025 Exploration Campaign on Bougainville Island, Papua New Guinea

ARAWA, Papua New Guinea, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Island Passage Exploration Limited (IPX or the “Company”) continues to explore the Isina exploration license (EL02) and achieve various...
February 13, 2025 12:22 ET | Source: Research and Markets

Nanotechnology Industry Report 2025-2035: Coverage of 40 Major Types of Nanomaterials - Cellulose Nanofibers, Graphene, Carbon Nanotubes, Silver Nanoparticles, Titanium Dioxide Nanoparticles & More

Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Global Nanotechnology Market 2025-2035" report has been added to ResearchAndMarkets.com's offering. Nanotechnology offers disruptive breakthroughs...
February 13, 2025 08:30 ET | Source: Elixirgen Therapeutics, Inc.

Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EXG-34217 for Treatment of Telomere Biology Disorders

BALTIMORE, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S. Food and Drug...